Forbion European Acquisition Corp.

Forbion European Acquisition Corp. (Nasdaq: FRBN) is a blank-check company sponsored by Forbion, a Netherlands-based life sciences venture capital firm with an established track record in European biopharmaceutical and medical technology investing. The company filed its S-1 registration statement with the SEC on November 23, 2021, targeting acquisition opportunities in the life sciences and healthcare sector. As a 2021-vintage SPAC, FRBN was structured to leverage Forbion's deep European deal network and domain expertise in drug development and biotech to identify a suitable business combination candidate. For full filing history, sponsor analytics, and status tracking on FRBN and thousands of other SPACs, sign up for complete data access at SpacDesk.